Revisiting an overlooked biomarker: CSF-IgA demonstrates significant diagnostic value for viral encephalitis in a case-control study
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1882946 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Dongxing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China. Hauptthemen laut MEDLINE: Biomarkers, Encephalitis, Viral. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Viral encephalitis (VE) is a serious central nervous system infection, yet its diagnosis is challenged by non-specific clinical manifestations, low pathogen detection rates, and often normal routine cerebrospinal fluid (CSF) findings. The diagnostic potential of CSF immunoglobulin A (CSF-IgA) has been largely overlooked. This study aimed to evaluate the diagnostic value of CSF-IgA for VE.
Methods
This single-center, retrospective case-control study analyzed data from 233 patients with VE and 80 symptomatic controls, collected over a 15.5-year period (January 1, 2010 to June 30 2025). A multivariable logistic regression model was constructed using variables that were significant in univariate analysis (p < 0.05). Model performance was rigorously evaluated in the overall cohort for discrimination (area under the receiver operating characteristic curve, AUC), calibration (using calibration plots and the Brier score), and clinical utility (via decision curve analysis). The model was further validated in a predefined subgroup of VE patients (n=50) with normal routine CSF findings, defined as normal CSF pressure, cell count, total protein, albumin, glucose, and chloride levels.
Results
The final parsimonious diagnostic model retained three robust predictors: CSF-IgA (OR 2.56, 95% CI: 1.73–4.06), CSF white blood cell count (OR 1.45, 95% CI: 1.25–1.76), and serum albumin (OR 0.81, 95% CI: 0.71–0.91). It demonstrated excellent discrimination in the overall cohort (AUC 0.933, 95% CI: 0.913–0.955), was well-calibrated (Brier score = 0.091), and provided superior net benefit across a wide threshold probability range. Importantly, robust performance was maintained in the clinically challenging subgroup with normal routine CSF parameters (AUC 0.812, 95% CI: 0.730–0.873; Brier score = 0.171).
Conclusions
CSF-IgA may serve as a promising adjunctive biomarker for viral encephalitis. A diagnostic model incorporating CSF-IgA showed good performance, even in atypical cases with normal routine CSF profiles, indicating its potential utility as an auxiliary tool for early VE diagnosis. However, given the single-center retrospective design, prospective external validation is warranted before routine clinical implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Pharmacy, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Intensive Care Medicine, Liuyang People's Hospital, Changsha, Hunan, China.
- Information and Big Data Center, The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Department of Emergency and Critical Care Medicine, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Zitieren
APA
Wang, D., Xu, J., Lv, B., Wang, R., Deng, S., Zhang, Y., Zou, R., Wang, Y., Zhou, B., Pan, J., & Cao, Y. (2026). Revisiting an overlooked biomarker: CSF-IgA demonstrates significant diagnostic value for viral encephalitis in a case-control study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1882946
Vancouver
Wang D, Xu J, Lv B, Wang R, Deng S, Zhang Y, et al. Revisiting an overlooked biomarker: CSF-IgA demonstrates significant diagnostic value for viral encephalitis in a case-control study. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1882946
BibTeX
@article{Wang2026,
author = {Wang, Dongxing and Xu, Jiaping and Lv, Bo and Wang, Rui and Deng, Shuangxiao and Zhang, Yanlin and Zou, Rong and Wang, Yu and Zhou, Baochun and Pan, Jie and Cao, Yongjun},
title = {Revisiting an overlooked biomarker: CSF-IgA demonstrates significant diagnostic value for viral encephalitis in a case-control study},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1882946}
}
EUVIMED